<DOC>
	<DOCNO>NCT02385279</DOCNO>
	<brief_summary>The primary objective study compare performance MISTENT XIENCE all-comers patient population symptomatic ischemic heart disease . The patient follow 3 year major clinical event .</brief_summary>
	<brief_title>Study Comparing MiStent SES Versus XIENCE EES Stent</brief_title>
	<detailed_description />
	<mesh_term>Coronary Stenosis</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<criteria>All comer '' patient : Male female patient 18 year old ; Presence one coronary artery stenoses 50 % native coronary artery saphenous venous arterial bypass conduit suitable coronary stent implantation . The vessel reference vessel diameter range 2.5 mm 3.75 mm ( limitation number treat lesion , vessel , lesion length ) ; All lesion patient must comply angiographic inclusion criterion . The patient judge capable provide voluntary informed consent fully inform nature study , willing comply study requirement provide write informed consent approve Ethics Committee respective clinical site . Known pregnancy breastfeed time randomization ; Known contraindication hypersensitivity sirolimus , everolimus , cobaltchromium , medication aspirin , heparin , bivalirudin , follow four medication : clopidogrel bisulfate , ticlopidine , prasugrel , ticagrelor ; Concurrent medical condition life expectancy le 12 month . The patient unwilling/ able return outpatient clinic 1 month 12 month followup . Currently participate another trial yet primary endpoint .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>CAD</keyword>
	<keyword>ACS</keyword>
	<keyword>All comer</keyword>
	<keyword>PCI</keyword>
</DOC>